Bortezomib, Thalidomide, and Dexamethasone After Melphalan and Stem Cell Transplant in Treating Patients With Stage I-III Multiple Myeloma

Name: Bortezomib, Thalidomide, and Dexamethasone After Melphalan and Stem Cell Transplant in Treating Patients With Stage I-III Multiple Myeloma
Published: 2008
License: Public Domain

City of Hope Medical Center · 2008

ClinicalTrials.gov · Datasets · License: Public Domain · 2008

Open Source ↗

neurotoxicity

multiple myeloma and plasma cell neoplasm, neurotoxicity, stage i multiple myeloma, stage ii multiple myeloma, stage iii multiple myeloma, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Bortezomib, Thalidomide, and Dexamethasone After Melphalan and Stem Cell Transplant in Treating Patients With Stage I-III Multiple Myeloma

Related documents